LL-3858 dihydrchloride

CAS No. 1044503-04-9

LL-3858 dihydrchloride( Sudoterb dihydrchloride )

Catalog No. M10218 CAS No. 1044503-04-9

A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 963 Get Quote
50MG 1962 Get Quote
100MG 2520 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    LL-3858 dihydrchloride
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL.
  • Description
    A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Sudoterb dihydrchloride
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1044503-04-9
  • Formula Weight
    592.4882
  • Molecular Formula
    C29H30Cl2F3N5O
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CC1=C(C=C(N1NC(=O)C2=CC=NC=C2)C3=CC=CC=C3)CN4CCN(CC4)C5=CC=CC(=C5)C(F)(F)F.Cl.Cl
  • Chemical Name
    N-[2-Methyl-5-phenyl-3-[[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]methyl]-1H-pyrrol-1-yl]-4-pyridinecarboxamide dihydrchloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Nuermberger EL, et al. Respirology. 2010 Jul;15(5):764-78. 2. Barry PJ, et al. Curr Med Chem. 2007;14(18):2000-8.
molnova catalog
related products
  • Ribocil-C

    A highly selective inhibitor of the FMN riboswitch that controls expression of de novo riboflavin (Vitamin B2) biosynthesis in Escherichia coli.

  • Salicyl-AMS

    Salicyl-AMS is an inhibitor of mycobacterium auxin biosynthesis that inhibits the growth of mycobacterium in the presence of iron deficiency in vitro.

  • Vancomycin

    An antibiotic used to treat a number of bacterial infections that acts by inhibiting proper cell wall synthesis.